Multivitamin use does not reduce the overall death rate nor the risk of cardiovascular disease nor most common cancers, according to recent results from the Women’s Health Initiative, which studies over 160,000 postmenopausal women.
A two-year study of over 800 overweight men and women concluded that high or low fat, protein or carbohydrate content made no difference in weight loss. Overall weight loss was modest, but not insignificant. But regular attendance at group or individual counseling sessions provided substantial benefit. NEJM 2.26.09
The JUPITER study (just published in the New England Journal of Medicine) solidly demonstrates that treatment of healthy middle-age and older people with low cholesterol values but elevated levels of an inflammatory marker (high-sensitivity CRP) with a powerful statin (Crestor) can substantially reduce the incidence of heart attacks, strokes and death. We need to reconsider our use of this test and its place in our approach to cardiovascular risk evaluation and treatment in each of our patients.
A new study, code-named Jupiter, has been released at the cardiology meetings in New Orleans, showing that Crestor (a statin drug) reduces heart disease and stroke in people whose cholesterol levels were already low, but where one test (the C-reactive protein) was elevated. What does this mean for you?